George D. Yancopoulos

Jan 26, 2024 | healio.com | Kristen Dowd |Marc E. Rothenberg |George D. Yancopoulos

Marc E. Rothenberg, MD, PhD The approval of dupilumab for children starting at age 1 year is an amazing advance for patients and families suffering from EoE. The scientific basis for using dupilumab for EoE is based in part by research conducted by my laboratory. I am grateful to the CURED Foundation and NIH and others for their long-term financial support, which provided critical funds that were leveraged for the basic research that led to this important advancement.

Feb 16, 2023 | dispatchist.com | George D. Yancopoulos

Regeneron names finalists of this year's Science Talent Search "The ball is in your court!" That was the message today from Regeneron's co-founder to the local finalists of this year's Science Talent Search!The Regeneron Science Talent Search scholars were selected from 1,949 applications from 627 high schools around the world.Each scholar receives a $2,000 award, while the big winner of the competition will receive an additional $25,000 scholarship.